GeneMind Biosciences is based in Shenzhen, China. It has raised $214M in total funding. Latest round: Series C.
GeneMind Biosciences is based in Shenzhen, China. GeneMind Biosciences has raised $214M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2023. The round record for GeneMind Biosciences runs through 2023; nothing later has been disclosed. Investors on record include Guoxin Investment, Guangzhou Kingmed Diagnostics Group. 2 distinct backers are named across the disclosed rounds.
Every GeneMind Biosciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shenzhen at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide